Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 26,046 | 23,749 | 24,064 | 23,870 | 25,309 |
| Cost of Goods | 11,148 | 7,686 | 6,157 | 5,807 | 6,063 |
| Gross Profit | 14,898 | 16,063 | 17,907 | 18,063 | 19,246 |
| Operating Expenses | 19,788 | 17,868 | 19,126 | 22,146 | 19,634 |
| Operating Income | -4,742 | -1,119 | -1,062 | -3,276 | -325 |
| Interest Expense | 223 | 26 | 44 | 52 | 101 |
| Other Income | 19 | 138 | 28 | 72 | 68 |
| Pre-tax Income | -4,946 | -1,007 | -1,078 | -3,256 | -358 |
| Income Tax | 84 | 46 | -83 | 163 | 42 |
| Net Income Continuous | -5,030 | -1,053 | -995 | -3,419 | -400 |
| Net Income | $-5,030 | $-1,053 | $-995 | $-3,419 | $-400 |
| EPS Basic Total Ops | -1,799.10 | -299.85 | -299.85 | -1,799.10 | -299.85 |
| EPS Basic Continuous Ops | -1,722.14 | -438.76 | -432.14 | -1,697.27 | -199.45 |
| EPS Diluted Total Ops | -1,799.10 | -299.85 | -299.85 | -1,799.10 | -299.85 |
| EPS Diluted Continuous Ops | -1,722.14 | -438.76 | -432.14 | -1,697.27 | -199.45 |
| EBITDA(a) | $-1,997 | $1,730 | $1,817 | $-16 | $2,878 |